Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Key facts
- Who runs it
- SightGlass Vision, Inc.
- Where
- Athens, Beaumont, Bellaire, Boston, Chicago, Granville, Longwood, Marietta, Oakland, Pittsburg, Raytown, San Diego, San Francisco, and Santa Ana, United StatesSee the 14 sites
- Trial code
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 18 Sept 2023
- Expected to end
- 31 Mar 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Single vision, impact-resistant spectacle lenses; Test Arm
- Single vision, impact-resistant spectacle lenses; Control Arm
- Record updated
- 29 December 2025
Who can take part
- Age
- 6 years to 8 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (18)Hide the full registry criteria
Who can take part
- Children 6 - 8 years of age (inclusive) at time of informed consent/assent
- Spherical equivalent refractive error between -0.75 and -4.50 D inclusive (by manifest refraction) in each eye
- Astigmatism if present, less than or equal to -1.25 DC (by manifest refraction) in each eye
- Best corrected visual acuity by manifest refraction of +0.10 logMAR (20/25 Snellen equivalent) or better in each eye
- The difference in spherical equivalent power between the two eyes (anisometropia based on manifest refraction) must be less than or equal to 1.50 D
- Agree to wear the assigned spectacles constantly except for sleeping, swimming, or other activities in which spectacle wear would be dangerous or otherwise not possible (minimum of 10 hours per day)
- Ability to comply with study procedures, including high and low contrast visual acuity, axial length, and cycloplegic autorefraction measurements taken for both eyes at the baseline visit
- Willingness to participate in the trial for 24 months without contact lens wear
- The subject's parent(s) or legal guardian(s) must read, understand and sign the Statement of Informed Consent and receive a fully executed copy of the form
Who cannot take part
- Subject has previously or currently wears contact lenses (greater than 1-month usage)
- Current or prior use of bifocals, progressive addition spectacle lenses
- Current or prior use of any myopia control treatment (e.g., atropine, multifocal contact lenses, orthokeratology)
- Any ocular or systemic conditions that could influence refractive development or status [e.g., keratoconus, congenital glaucoma, ocular trauma, diabetes, Marfan syndrome or other connective tissue disorder, Down's syndrome, family history of poor night vision (to prevent against enrolling subjects with congenital stationary night blindness)]
- Known allergy to proparacaine, tetracaine, or tropicamide
- Amblyopia in either eye
- Strabismus by cover test at far (4 m) or near (40 cm) wearing distance correction
- Participation in any investigational clinical study within 30 days of the Baseline visit
- Subject's sibling or other household member is already enrolled in this trial
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Myopia
This trial is currently available in United States.
- Athens Eye CareAthens, United StatesContact: Jen BriteTaking people
- Texas State Optical - DowlenBeaumont, United StatesContact: Bobbie HamptonTaking people
- Bellaire Family Eye CareBellaire, United StatesContact: Ashley Tucker, ODTaking people
- New England College of OptometryBoston, United StatesContact: Lilly CheamTaking people
- Ilinois College of OptometryChicago, United StatesContact: Jessica MartinezTaking people
- Procare Vision Centers, Inc.Granville, United StatesContact: Katherine Bickle, ODTaking people
- Omega Vision CenterLongwood, United StatesContact: Renee WarrenTaking people
- Marietta Eye ClinicMarietta, United StatesContact: Doreatha KennerlyTaking people
- Elsa Pao, ODOakland, United StatesContact: Vanessa ChenTaking people
- Kannarr Eye CarePittsburg, United StatesContact: Megan Compton, RNTaking people
- Advanced Eyecare, PCRaytown, United StatesContact: Tamara UriasTaking people
- Scripps Poway EyecareSan Diego, United StatesContact: Leslie Shan, ODTaking people
- Pacific Rims OptometrySan Francisco, United StatesContact: Aileen GuzmanTaking people
- Paje OptometricSanta Ana, United StatesContact: Daisy MagdalenoTaking people
About the trial
What the trial wants to find out
This is a conventional efficacy trial to validate the results from previous clinical trials for younger children; the 12-month efficacy results will be used to predict the 3-year treatment efficacy.
Read full original descriptionShow less
This is a randomized, controlled (1:1), multisite, subject- and observer-masked, 2-arm parallel group study.
The 2 groups in the trial
- Test Arm 1Treatment being tested
Single vision, impact-resistant spectacle lenses
Treatment: Single vision, impact-resistant spectacle lenses; Test Arm
- Test Arm 2Other group
Single vision, impact-resistant spectacle lenses
Treatment: Single vision, impact-resistant spectacle lenses; Control Arm
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT06034327, who can take part
- Record updated
- 29 December 2025